Skip to main content
logo
Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
6.79
-0.02 (-0.29%)
Apr 30, 2026, 3:00 PM CST

SHA:605199 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,7173,0496,3746,0666,4109,971
Market Cap Growth
-55.79%-52.17%5.08%-5.37%-35.71%3.32%
Enterprise Value
3,8564,3007,5967,0396,74910,111
Last Close Price
6.797.6215.9314.9715.8224.60
PE Ratio
---558.9774.81138.22
PS Ratio
3.023.384.513.384.237.37
PB Ratio
5.936.668.575.706.3110.72
P/TBV Ratio
12.3113.8212.597.117.0312.25
P/FCF Ratio
51.0857.33----
P/OCF Ratio
19.8522.28-214.7026.8597.29
EV/Sales Ratio
4.284.775.373.924.457.47
EV/EBITDA Ratio
---94.9846.9486.08
EV/EBIT Ratio
---323.7369.20139.08
EV/FCF Ratio
72.5180.86----
Debt / Equity Ratio
2.562.561.881.210.670.54
Debt / EBITDA Ratio
---15.904.604.13
Debt / FCF Ratio
22.0522.05----
Net Debt / Equity Ratio
2.392.391.540.710.200.01
Net Debt / EBITDA Ratio
-17.52-17.52-5.5810.241.420.10
Net Debt / FCF Ratio
20.5820.58-3.75-1.65-1.33-0.33
Asset Turnover
0.320.320.480.680.740.83
Inventory Turnover
1.821.822.053.613.022.74
Quick Ratio
0.360.360.470.950.891.07
Current Ratio
0.610.610.851.271.181.37
Return on Equity (ROE)
-47.34%-47.34%-29.83%1.63%8.71%7.53%
Return on Assets (ROA)
-3.59%-3.59%-5.89%0.52%2.99%2.77%
Return on Invested Capital (ROIC)
-9.15%-9.29%-15.00%0.90%7.87%6.90%
Return on Capital Employed (ROCE)
-13.80%-13.80%-18.20%1.20%7.80%7.50%
Earnings Yield
-10.58%-9.43%-4.31%0.18%1.34%0.72%
FCF Yield
1.96%1.74%-4.79%-7.60%-2.40%-0.35%
Dividend Yield
---0.83%--
Payout Ratio
---290.87%16.75%102.23%
Buyback Yield / Dilution
-0.34%-0.34%-9.97%11.35%-1.81%-5.55%
Total Shareholder Return
-0.34%-0.34%-9.97%12.18%-1.81%-5.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.